ENLARGE TEXT
Screening for C-reactive protein 

Screening for Elevated C-Reactive Protein

The high-sensitivity C-reactive protein (hs-CRP) screening measures CRP levels in the blood. CRP is part of your immune system and becomes elevated in your blood as a result of infection or inflammation. It is believed that high CRP levels are associated with cardiovascular disease, stroke, coronary heart disease, peripheral arterial disease, and type 2 diabetes.


What you can learn
Although CRP is an independent risk factor for cardiovascular disease, it should not be the sole factor used to identify risk. Other risk factors including age, family history, blood pressure, smoking status, weight, exercise level, and stress level are also considered when assessing cardiovascular disease risk. Your CRP level will fall into one of these categories:


hs-CRP
Value
Cardiovascular Disease Risk Level*
< 1 mg/L
low risk
1-3 mg/L
average risk
> 3 mg/L
high risk
* Risk levels published in 2003. American Heart Association / Centers for Disease Control and Prevention Scientific Statement


If you CRP level is >10 mg/L, we will recommend you be screened again at least 2 to 3 weeks later because a very high level can indicate a separate infection or illness in your body.


Who should have it
Anyone who has risk factors for heart disease, peripheral arterial disease, diabetes, or stroke should have this screening. Find out if you are at risk for any of these diseases:

Heart disease
Peripheral arterial disease
Diabetes
Stroke


How often to get screened
This is a personal decision based on your risk factors and previous screening results. Many of our customers have an annual screening as part of their regular healthcare regimen.


How to prepare
There is nothing you need to do in advance for this screening. Unlike other finger-stick blood screenings, this does not require fasting.

SIGN UP FOR  A SCREENING TODAY.

Find out if you are at risk for common diseases including stroke, heart disease, diabetes, peripheral arterial disease, and more.